Kingdon Capital

Total investments

18

Average round size

57M

Portfolio companies

16

Rounds per year

0.44

Lead investments

3

Follow on index

0.11

Exits

11

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareManufacturingMedicalLife SciencePharmaceuticalTherapeuticsTelecommunications

Summary

Kingdon Capital is the famous Corporate Investor, which was founded in 1983. The leading representative office of defined Corporate Investor is situated in the New York. The company was established in North America in United States.

The higher amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. This Kingdon Capital works on 51 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Kingdon Capital, startups are often financed by North Bridge Venture Partners & Growth Equity, Battery Ventures, Viola Ventures. The meaningful sponsors for the fund in investment in the same round are Viola Ventures, Van Wagoner Ventures, LLC, North Bridge Venture Partners & Growth Equity. In the next rounds fund is usually obtained by Wellington Financial, Visa International Service Association, Viola Ventures.

Among the most successful fund investment fields, there are E-Commerce, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Luminous Networks, SandCraft, Napo Pharmaceuticals. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
18
Lead investments
3
Exits
11
Rounds per year
0.44
Follow on index
0.11
Investments by industry
  • Biotechnology (10)
  • Medical (7)
  • Pharmaceutical (4)
  • Health Care (4)
  • Telecommunications (4)
  • Show 22 more
Investments by region
  • United States (14)
  • Switzerland (1)
  • Latvia (1)
  • Australia (1)
  • Israel (1)
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
155M
Group Appearance index
0.89
Avg. company exit year
11
Avg. multiplicator
2.12

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Sapience Therapeutics 31 May 2022 Biotechnology, Medical, Therapeutics Early Stage Venture 41M United States, New York

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.